| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Promotes NSCLC cell growth, proliferation, clonogenic capacity, migration, invasion, EMT and xenograft tumor growth; inhibits apoptosis. |
| Molecular mechanism: |
hsa_circ_0007534 exerts oncogenic properties partly by suppressing caspase-3 and caspase-9-associated apoptosis and by affecting the EMT pathway, including regulation of E-cadherin, Snail, N-cadherin and Vimentin protein levels. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Cohort Study; Survival Analysis |
| Clinical significance: |
Up-regulation is linked to lymph node invasion and advanced TNM stage; high expression predicts shorter survival and serves as an independent unfavorable prognostic predictor for 5-year overall survival in NSCLC patients. |
| Description: |
hsa_circ_0007534 is up-regulated in NSCLC tissues and cell lines and its high expression is associated with lymph node invasion, advanced TNM stage and poor overall survival. Functionally, it promotes NSCLC cell proliferation, colony formation, migration, invasion, EMT and xenograft tumor growth while inhibiting apoptosis, suggesting an oncogenic and prognostic role. |
| Confidence score: |
0.6742 |